Improved renal transplant survival with cyclosporin in patients without high molecular weight serum Fc gamma-receptor blocking activity.
McMillan
M A
MA
Renal Unit, Western Infirmary, Glasgow, Scotland.
Cocker
J E
JE
Briggs
J D
JD
Junor
B J
BJ
MacSween
R N
RN
Sandilands
G P
GP
D000943:Antigens, Differentiation / Q000276:immunology*; D001379:Azathioprine / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood*; D003524:Cyclosporins / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D016030:Kidney Transplantation; D008970:Molecular Weight; D011239:Prednisolone / Q000627:therapeutic use; D011961:Receptors, Fc / Q000276:immunology*; D017452:Receptors, IgG
D000943:Antigens, Differentiation; D015415:Biomarkers; D003524:Cyclosporins; D007074:Immunoglobulin G; D011961:Receptors, Fc; D017452:Receptors, IgG; D011239:Prednisolone; D001379:Azathioprine